기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
Functional Impairment of P-glycoprotein by Sodium Nitroprusside Pretreatment in Mouse Brain Capillary Endothelial Cells
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • Functional Impairment of P-glycoprotein by Sodium Nitroprusside Pretreatment in Mouse Brain Capillary Endothelial Cells
  • Functional Impairment of P-glycoprotein by Sodium Nitroprusside Pretreatment in Mouse Brain Capillary Endothelial Cells
저자명
Maeng. Han-Joo,Bang. Yu-Jin,Chung. Suk-Jae
간행물명
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
권/호정보
2012년|35권 7호|pp.1215-1221 (7 pages)
발행정보
대한약학회
파일정보
정기간행물|ENG|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

We examined whether pretreatment of mouse brain blood vessel endothelial cell clone 4 (MBEC4) cells with sodium nitroprusside (SNP), a $NO_x$ donor, as an in vitro model of the blood-brain barrier could affect P-glycoprotein (P-gp) functional activity. Uptake into the cells and MBEC4 plasma membrane vesicles (MPMVs) in the presence or absence of SNP pretreatment was used to investigate functional changes. Increased accumulation of $[^3H]$vincristine, a widely used substrate for P-gp, into MBEC4 was observed upon SNP pretreatment, likely due to impaired P-gp function. To better understand the mechanism of the impairment, MPMVs were prepared and characterized in terms of purity and $Na^+$-dependent glucose uptake. $[^3H]$daunomycin uptake into MPMVs was diminished after SNP pretreatment in the presence of an ATP-regenerating system, indicating that the functional activity of P-gp was impaired after exposure to SNP. Under conditions of excess ATP, daunomycin uptake into the vesicles was still decreased after SNP pretreatment, indicating that SNP interacted directly with the transport system, but not with the ATP-regenerating system. Together, these results suggest that NO or $NO_x$ functionally impairs P-gp in the in vitro blood-brain barrier model with SNP pretreatment.